By Edgardo Lopez
Imagine
a clinical program that will help you to prevent, diagnose and treat a disease
like cancer o a cardiovascular disease by using your DNA information? A group
of scientist led by Dr. Leslie G. Biesecker
develop a project were the genome takes a big role in the discoveries of
treatments for different diseases. One of Clinseq project main goal is to use
whole genome sequencing to have a better DNA profile of each patient compare to
there family and other patient with heart disease, breast cancer, and hearing loss.
This study also want to explain how genetic variation affect our health,
present the genetic results to the people and also create better ways to store
genetic data and analyze the complexity no matter what. In this study they work
with a cohort of people with a background in Atherosclerosis heart disease.
¿What is Atherosclerosis heart disease?
This a disease in witch your plaque block your arteries
causing major problems like heart attacks, strokes or even death.
By elucidation the human genome we have discover new
advances in DNA sequencing technologies and new ways to interpret the genetic
architecture of the DNA related to some diseases. Using the whole genome is a
better approach to understand the variability and complexity of the genome and by
taking multiple gene analysis we can get a better point of view of what is
expressing in our cells and what not. The design of this study is base on an
analysis of 1000 individuals in the National Institutes of Health. Taking DNA
samples for sequencing is one of the most important steps in this project since
there are issues in the effectivity of the data obtained by sequencing. Each
individual will get a multiple analysis of variant that will collaborate with
the clinical sector for a genetic and medical counseling. Clinseq is one of the most important approach
for medical science that use whole-genome analyses and a clinical approach. For
each patient there is a enrollment process to participate of this program. Each
patient need to provide a clinical background of the atherosclerotic hears
disease in their family and also in them. DNA samples are taken for clinical
evaluation and for research. The research samples pass throw a bioinformatics analysis
and then is validate with the clinical data to learn and discover the relevant
information that can lead to a better treatment for the patient.
Reference:
Biesecker et. al. 2009. The ClinSeq Project: Piloting
large-scale genome sequencing for research in genomic medicine. 19:1665–1674;
ISSN 1088-9051/09; www.genome.org
What is Atherosclerosis? NIH National Heart, Lungs and Blood Institute http://www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis
No comments:
Post a Comment